Industry News
Snapshot Of Fleeting Protein Process Shows How Actin Nucleation Begins
Jun 03, 2013
Structural biologists from Rice University and Baylor College of Medicine (BCM) have captured the first three-dimensional crystalline snapshot of a critical but fleeting process that takes place thousands of times per second in each human cell. The research appears online in the journal Cell Reports and could prove useful in the study of cancer and other diseases... Read More
Stimulating The Immune System To Fight Brain Tumors
Jun 03, 2013
Research at Lund University in Sweden gives hope that one of the most serious types of brain tumor, glioblastoma multiforme, could be fought by the patients' own immune system. The tumors are difficult to remove with surgery because the tumor cells grow into the surrounding healthy brain tissue... Read More
Novel Approach Identified For Creating Red Blood Cells, Platelets In Vitro
Jun 03, 2013
A study led by Boston University School of Medicine has identified a novel approach to create an unlimited number of human red blood cells and platelets in vitro... Read More
First Drug To Help Melanoma Of The Eye
Jun 02, 2013
AstraZeneca's experimental drug, selumetinib, is the first targeted medication to show a significant clinical benefit for patients with melanoma of the eye (metastatic uveal melanoma), researchers from the Memorial Sloan-Kettering Cancer Center explained at the 49th annual meeting of the American Society of Clinical Oncology (ASCO), in Chicago, Illinois... Read More
Some Patients With Treatment-Resistant Colorectal Cancers May Have A New Option
Jun 02, 2013
A subset of colorectal cancers responds to anti-epidermal growth factor receptor (anti-EGFR) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR therapy, some showed overexpression of a gene called MET, according to a study published in the June issue of Cancer Discovery, a journal of the American Association for Cancer Research... Read More
Promising New Therapy For Lung Cancer
Jun 01, 2013
A novel therapy for the most common form of lung cancer shows promise and seems to yield largely manageable side effects, according to new research that will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology... Read More
What Is Warfarin?
Jun 01, 2013
Warfarin is an anticoagulant medication - it is used to slow down the blood-clotting process. Anticoagulants are used to prevent blood clots which may cause vein blockages, heart attack and stroke. Warfarin is known under the brand names Warfant, Jantoven, Coumadin, Lawarin, Marevan, and Waran. Doctors prescribe warfarin for people who are at a higher risk of forming blood clots... Read More
Father And Son To Present Their Respective Cancer Research At ASCO
Jun 01, 2013
What started as a dinner-table conversation between a teen and his father has become a bonafide cancer research study for Matthew Lara, a Davis High School sophomore and the son of UC Davis Comprehensive Cancer Center medical oncologist and researcher Primo (Lucky) Lara... Read More
Exposure To Dry-Cleaning Solvent And Degreaser TCE Linked To Increased Risk Of Some Cancers
Jun 01, 2013
Trichloroethylene (TCE) exposure has possible links to increased liver cancer risk, and the relationship between TCE exposure and risks of cancers of low incidence and those with confounding by lifestyle and other factors need further study, according to a study published in the Journal of the National Cancer Institute... Read More
Promising New Therapy For Lung Cancer
May 31, 2013
A novel therapy for the most common form of lung cancer shows promise and seems to yield largely manageable side effects, according to new research that will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology... Read More
Previous Page Next Page